source
- FDA provides minimal comment on Grail cancer test before advisory committee meetingThe FDA typically releases briefing documents that give a clear stance on a drug or diagnostic's safety and efficacy before its advisory committee convenes. In the upcoming meeting concerning Grai…
- Novo outlines plan for multiple new drugs to regain market share as shares dip 8%At a capital markets day in London, Novo executives presented a roadmap to launch more than five multi-blockbuster drugs by 2030 and target $23 billion in annual sales by 2035, aiming to offset the…